The phrase "a biological defect" is correct and usable in written English.
It can be used in contexts discussing genetic or physiological abnormalities or conditions that affect an organism's biological functions.
Example: "The study focused on identifying the causes of a biological defect that led to developmental issues in the affected population."
Alternatives: "a genetic anomaly" or "a physiological impairment".
Koch paces his revelations expertly, and there are twists and turns enough to keep us reading, but his decision to ascribe the former teacher's violent outbreaks to a biological defect – to make Paul's condition something other than simply the human condition – diminishes the book.
Though Asperger regarded it as a biological defect of affective contact innate, inborn, analogous to a physical or intellectual defect Kanner tended to view it as a psychogenic disorder, a reflection of bad parenting, and most especially of a chillingly remote, often professional "refrigerator mother".
Though Asperger regarded it as a biological defect of affective contact — innate, inborn, analogous to a physical or intellectual defect — Kanner tended to view it as a psychogenic disorder, a reflection of bad parenting, and most especially of a chillingly remote, often professional "refrigerator mother".
Therefore lower or higher lipid content is a biological defect.
The substitution of one (lower value) fish species for another (high value) is an example of a biological defect, fraud.
For example, retinal cells can be generated in culture from patient-derived iPSCs and used to study whether the introduction of specific genes into these cells can compensate for a biological defect in their function.
In acute toxicity study, the B. ceiba extract was found to be safe and did not reveal any biological defect and mortality in rodents.
Current treatments are largely symptomatic and supportive, and do not reverse the underlying biological defect in the lung.
Mutational patterns, which are probably more closely related to the underlying biological defect, therefore appear to report similarities in disease pathogenesis between BRCA1 and BRCA2 mutant cancers better than cellular phenotype.
Given the double burden of β cell dysfunction and insulin resistance in Asian T2D patients, mediated in part by adiposity, there are strong arguments to advocate the use of phenotypes to guide therapies targeted at the predominant biological defect to achieve glycemic control early and preserve β cell function by reducing gluco-lipotoxicity.
However, underproliferation is the most common phenotype in our analysis (538 of 620 genes) and can also arise from a number of unspecific biological defects, such as cell death or cell-cycle block.
